Calimmune

Calimmune

Biotechnology, 35 N Lk Ave, Pasadena, California, 91101, United States, 1-10 Employees

calimmune.com

  • LinkedIn

phone no Phone Number: +13*********

Who is CALIMMUNE

Calimmune was founded in 2006 based on breakthrough gene modification and cell delivery technology developed in the labs of Nobel Laureate David Baltimore, Ph.D. (California Institute of ...

Read More

map
  • 35 N Lk Ave, Pasadena, California, 91101, United States Headquarters: 35 N Lk Ave, Pasadena, California, 91101, United States
  • 2006 Date Founded: 2006
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CALIMMUNE

Calimmune Org Chart and Mapping

Employees

Suparna Mishra

Quality Assurance Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Calimmune

Answer: Calimmune's headquarters are located at 35 N Lk Ave, Pasadena, California, 91101, United States

Answer: Calimmune's phone number is +13*********

Answer: Calimmune's official website is https://calimmune.com

Answer: Calimmune's revenue is $10 Million to $25 Million

Answer: Calimmune's SIC: 2836

Answer: Calimmune's NAICS: 541714

Answer: Calimmune has 1-10 employees

Answer: Calimmune is in Biotechnology

Answer: Calimmune contact info: Phone number: +13********* Website: https://calimmune.com

Answer: Calimmune was founded in 2006 based on breakthrough gene modification and cell delivery technology developed in the labs of Nobel Laureate David Baltimore, Ph.D. (California Institute of Technology), Irvin Chen, Ph.D. (University of California, Los Angeles) and Inder M. Verma, Ph.D. (Salk Institute for Biological Studies). Calimmune is accelerating the promise of gene therapy to liberate patients from chronic and currently incurable diseases. To achieve our ambitious goal, we have built a suite of technologies to advance the delivery, manufacturing, and overall efficiency of these life-changing medicines. Calimmune's lead development programs are novel ex-vivo gene therapies for hematologic diseases. We are privileged to have some of the worlds most respected gene therapy developers, clinicians, scientific advisors and commercialization experts committed to our mission. We are passionate about what we do, and for those we ultimately seek to serve.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access